Genome & Company
- Biotech or pharma, therapeutic R&D
Genome & Company, Inc. is a South Korea-based biotechnology company specializing in discovery and development of novel target therapeutic agents with first-in-class potential, including but not limited to novel cancer target antibodies as stand-alone therapy and antibody-drug conjugate (ADC) applications, and novel fibrosis target small molecule candidate. The company leverages its GNOCLE™ drug discovery and development platform, a unique bed-to-bench approach based on real-world clinical data.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}